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Summary 
Recent studies demonstrate that natural killer (NK) cells have adaptive immune 
features. Here, we investigated the role of the costimulatory molecule DNAM-1 in the 
differentiation of NK cells in a mouse model of cytomegalovirus (MCMV) infection.  
Antibody blockade of DNAM-1 suppressed the expansion of MCMV-specific Ly49H+ 
cells during viral infection and inhibited the generation of memory NK cells.  Similarly, 
DNAM-1-deficient (Cd226-/-) Ly49H+ NK cells exhibited intrinsic defects in expansion 
and differentiation into memory cells.  Src-family tyrosine kinase Fyn and serine - 
threonine protein kinase C isoform eta  (PKCh) signaling through DNAM-1 played 
distinct roles in the generation of MCMV-specific effector and memory NK cells. Thus, 
cooperative signaling through DNAM-1 and Ly49H are required for NK cell-mediated 
host defense against MCMV infection. 
  
Highlights 
l DNAM-1 is required for the expansion and generation of memory NK cells 
l Fyn and PKCh play distinct role in DNAM-1 signaling in Ly49H+ NK  
l DNAM-1 is dynamically regulated on NK cells during MCMV infection 
l MCMV infection up-regulates DNAM-1 ligands on dendritic cells and macrophages 
Introduction 
Natural killer (NK) cells are traditionally classified as innate immune cells because they 
rapidly respond to pathogens and are considered short-lived and unable to differentiate 
into memory cells (Lanier, 2005; Min-Oo et al., 2013; Sun et al., 2010).  Accumulating 
evidence, however, indicates that NK cells have adaptive immune features (Cooper et 
al., 2009; Min-Oo et al., 2013; O'Leary et al., 2006; Paust et al., 2010; Sun et al., 2009, 
2010, 2011).  In some cases, NK cells are activated after exposure to pathogens, 
antigens, and cytokines, and subsequently differentiate into a long-lived population with 
enhanced effector function in response to a variety of secondary stimuli, as compared 
with naive NK cells (Cooper et al., 2009; O'Leary et al., 2006; Sun et al., 2009).  The 
existence of memory NK cells in humans is suggested by the extensive expansion and 
persistence for months of NKG2C+ NK cells following infection with human 
cytomegalovirus (HCMV) (Foley et al., 2012a; Foley et al., 2012b; Lopez-Vergès et al., 
2011; Min-Oo et al., 2013).  We have previously demonstrated that mouse NK cells 
bearing the Ly49H receptor, which specifically recognizes the m157 mouse 
cytomegalovirus (MCMV) glycoprotein on the infected cells (Arase et al., 2002), 
undergo activation, a robust expansion, contraction, differentiation into a long-lived 
memory subset, and persistence in both lymphoid and non-lymphoid organs for several 
months after MCMV infection (Sun et al., 2009, 2010).  These memory NK cells are 
capable of mounting a recall response to MCMV infection and protect the host better 
than naive NK cells (Sun et al., 2009).  The kinetics of differentiation of Ly49H+ NK cells 
during MCMV infection are similar to virus-specific CD8+ T cells. NK cells and CD8+ T 
cells arise from a common lymphoid progenitor, express many shared cell surface 
antigens, secrete a similar array of cytokines, and most importantly, perform common 
functions including perforin and granzyme-mediated cytotoxicity (Sun et al., 2009, 2011; 
Sun and Lanier, 2011).  Although DAP12 adaptor protein ITAM-mediated signaling 
through Ly49H and the pro-inflammatory cytokine interleukin-12 (IL-12) are known to be 
essential for optimal expansion of effector Ly49H+ NK cells and for the generation of 
memory Ly49H+ NK cells during MCMV infection (Sun et al., 2009, 2012), the 
contribution of signaling through other receptors required for the differentiation of 
MCMV-specific NK cells have not been defined. 
DNAM-1 (DNAX accessory molecule-1, CD226) is a costimulatory molecule that 
is constitutively expressed by NK cells and CD8+ T cells (Shibuya et al., 1996).  DNAM-
1 recognizes CD155 and its related family member, CD112, as cognate ligands (Bottino 
et al., 2003; Tahara-Hanaoka et al., 2004), which are broadly expressed by 
hematopoietic, epithelial, and endothelial cells in many tissues (Aoki et al., 1997; 
Nabekura et al., 2010; Ravens et al., 2003).  DNAM-1 has signal-transducing motifs in 
its cytoplasmic domain for the recruitment of the tyrosine kinases Fyn and serine-
threonine kinase PKC (Shibuya et al., 1998; Shibuya et al., 1999; Shirakawa et al., 
2005; Shirakawa et al., 2006).  Interaction between DNAM-1 on NK cells and CD8+ T 
cells with its ligands on target cells triggers cell-mediated cytotoxicity and cytokine 
production (Bottino et al., 2003; Iguchi-Manaka et al., 2008; Shibuya et al., 1996).  
DNAM-1 is also involved in NK cell- and CD8+ T cell-mediated tumor rejection, as 
demonstrated using transplantable tumor models but also in immune surveillance of 
carcinogen-induced tumorigenesis (Iguchi-Manaka et al., 2008; Tahara-Hanaoka et al., 
2006).  Recently, DNAM-1 has been shown to co-stimulate the proliferation and 
interferon-g (IFN-g) production of alloantigen-specific CD8+ T cells (Nabekura et al., 
2010).  Thus, DNAM-1 plays a critical role in the functions of NK cells and CD8+ T cells 
for the elicitation of appropriate immune responses.  Here, using the well-established 
model of MCMV infection (Sun et al., 2009), we investigated the role of DNAM-1 in the 
differentiation and function of MCMV-specific memory NK cells. 
  
Results[  
DNAM-1 is expressed on immature and mature NK cells 
We examined whether DNAM-1 correlates with the maturation stage of NK cells or 
is required for NK cell-mediated effector functions in vitro.  Approximately 80-90% 
of NK cells in the spleen, blood, bone marrow (BM), and liver of C57BL/6 mice 
expressed DNAM-1 (Figure 1A).  Similar frequencies of immature (CD27+CD11b-), 
intermediate (CD27+CD11b+), and mature (CD27-CD11b+) NK cells were present within 
the DNAM-1+ and DNAM-1- subsets (Figure 1B). DNAM-1- and DNAM-1+ NK cells 
expressed equivalent amounts of IL-2 receptor b and g!subunits, IL-7Ra, and IFN-aR1 
(not shown).  The Ly49H receptor was expressed on a higher frequency of DNAM-1- NK 
cells (~60-85% Ly49H+) compared with DNAM-1+ NK cells (~40-50% Ly49H+) (Figure 
1C).  Within the DNAM-1- and DNAM-1+ Ly49H+ NK cell subsets the frequency of NK 
cells expressing Ly49C and/or Ly49I,  inhibitory receptors that recognizes self H-2b 
ligands (marking licensed NK cells), was identical (Figure 1D). 
 Ly49H specifically recognizes the MCMV-encoded m157 glycoprotein (Arase et 
al., 2002; Smith et al., 2002). Similar frequencies of DNAM-1- and DNAM-1+ Ly49H+ 
degranulated and produced IFN-g when co-cultured with RMA target cells transduced to 
express m157 (Figure 1E).  Co-expression of CD155, a ligand of DNAM-1, on the 
m157+ RMA cells did not increase the frequency of Ly49H+ NK cells degranulating or 
producing IFN-g.  In a similar fashion we adoptively transferred wildtype (WT) Ly49H+ 
NK cells into syngeneic DAP12-deficient recipient mice, which lack functionally 
competent Ly49H+ NK cells and are unable to control early replication of MCMV (Sjölin 
et al., 2002; Sun et al., 2009). After infection with MCMV, both DNAM-1- and DNAM-1+ 
Ly49H+ NK cells produced IFN-g!on day 1.5 post-infection (pi) (Figure 1F). These 
findings demonstrate that DNAM-1 is not required for m157-induced degranulation or 
cytokine production by Ly49H+ NK cells. 
 
DNAM-1 antibody blockade suppresses the NK cell response to MCMV 
We addressed the role of DNAM-1 in the control of MCMV by treating C57BL/6 mice 
with a non-depleting, neutralizing anti-DNAM-1 mAb one day prior to infection and 
measured viral titers on day 3, when NK cells are predominantly responsible for anti-
viral immunity.  Blocking DNAM-1 resulted in a significant increase in viral load in the 
spleen and liver (Figure 2A).  
Ly49H+ NK cells preferentially expand after MCMV infection and are required for 
early control of viral replication (Brown et al., 2001; Dokun et al., 2001; Lee et al., 2001).  
When a limiting number of Ly49H+ NK cells are adoptively transferred into Ly49H-
deficient mice and infected with MCMV, these Ly49H+ NK cells undergo extensive 
expansion and give rise to memory Ly49H+ NK cells (Sun et al., 2009).  Monitoring of 
donor Ly49H+ NK cells in the blood reflects the responses in the spleen and liver, as 
previously demonstrated (Sun et al., 2010).  Memory Ly49H+ NK cells can be 
operationally defined as KLRG1high, CD11b+, CD27-, Ly6Chigh Ly49H+ NK cells that 
persist for more than 25 days after infection with MCMV.  To determine the effect of 
DNAM-1 blockade on the clonal expansion of Ly49H+ NK cells and generation of 
memory NK cells, we enriched NK cells and adoptively transferred wildtype (WT) 
Ly49H+ NK cells into syngeneic DAP12-deficient recipient mice (Figure S1).  These 
mice were injected with a neutralizing anti-DNAM-1 mAb on the day before infection and 
on day 3 pi.  Expansion of donor Ly49H+ NK cells at the peak of the NK cell response 
during MCMV infection was suppressed by anti-DNAM-1 antibody (Figure 2B); however, 
Ly49H+ NK cells were detected at day 28 in the mice treated with anti-DNAM-1 on days 
-1 and 3 pi.  These NK cells were able to undergo a secondary response when 
adoptively transferred into naive Ly49H-deficient recipients and challenged with MCMV 
(not shown).  Therefore, to address whether DNAM-1 antibody blockade affects the 
persistence of Ly49H+ NK cells after the peak of the response, Ly49H+ NK cells were 
adoptively transferred into DAP12-deficient recipients, infected with MCMV, and mice 
were treated with control Ig or neutralizing anti-DNAM-1 on days 7, 14, and 21 pi, and 
analyzed on day 28 pi.  Blockade of DNAM-1 during the late phase of infection resulted 
in significantly fewer Ly49H+ NK cells at day 28, suggesting that sustained DNAM-1 
signaling is required for establishment of an optimal pool of memory NK cells (Figure 
2C).  
     
Intrinsic lack of DNAM-1 impairs Ly49H+ NK cell response to MCMV 
In addition to NK cells, DNAM-1 is expressed on CD8+ T cells and subsets of CD4+ T 
cells and dendritic cells (DCs) (Dardalhon et al., 2005; Iguchi-Manaka et al., 2008).  
Therefore, treatment with the blocking anti-DNAM-1 might affect the response of other 
immune cells during MCMV infection. To determine whether an intrinsic lack of DNAM-1 
affects NK cells we reconstituted lethally irradiated recipient mice with CD45.1+ WT and 
CD45.2+ Cd226-/- BM cells and allowed NK cells to reconstitute in the recipient mice for 
5 weeks.  At this time, an equivalent frequency of mature WT and Cd226-/- NK cells was 
detected in the blood and spleen of the chimeric mice, consistent with prior studies 
documenting normal development and numbers of NK cells in Cd226-/- mice (Gilfillan et 
al., 2008).  Ly49H+ NK cells were isolated from the chimeric mice, adoptively transferred 
into Ly49H-deficient mice, and then infected with MCMV (Figure 3A). During the early 
phase of the response to MCMV infection, Cd226-/- Ly49H+ NK cells were activated 
comparably to WT Ly49H+ NK cells, as reflected by up-regulation of Sca-1, CD69, and 
KLRG1, and WT and Cd226-/- Ly49H+ NK cells produced identical amounts of IFN-g on 
day 1.5 pi (Figure 3B and data not shown).  Ly49H+ effector and memory NK cells highly 
expressed KLRG1 and predominantly displayed a mature phenotype (CD11b+, CD27-, 
and Ly6Chigh) on day 7 and day 25 pi, respectively (Figure 3C). However, Cd226-/- 
Ly49H+ NK cells showed severe defects in expansion of effector NK cells, as well as in 
the generation of long-lived NK cells (Figure 3D and Figure S2).  Cd226-/- Ly49H+ NK 
cells isolated from the MCMV-infected mice and adoptively transferred into naive 
Ly49H-deficient recipient mice expanded poorly when re-challenge with MCMV (Figure 
3E).  Moreover, when Cd226-/- Ly49H+ memory NK cells were adoptively transferred 
into a naive Ly49H-deficient or DAP12-deficient host they showed an impaired 
protective effect against MCMV challenge on days 3 pi and 7 pi (Figures 3F and 3G; 
Figure S3), although MCMV-specific T cell responses are mounted and decrease the 
viral burden on day 7 pi (Schlub et al., 2011).  These results demonstrate that DNAM-1 
is essential for the optimal differentiation of effector and memory Ly49H+ NK cells during 
MCMV infection, but is dispensable for the initial activation of NK cells. 
 
DNAM-1 signaling is mediated by Fyn and PKCh  
Previous studies have demonstrated that signaling through DNAM-1 is mediated by Fyn 
and PKC (Shibuya et al., 1999; Shirakawa et al., 2005), although which PKC isozymes 
are responsible had not been identified.  We speculated that PKCh might be 
responsible for DNAM-1-dependent PKC signaling.  This possibility is based on prior 
studies where phosphorylation of the cytoplasmic motifs of DNAM-1 was assessed in 
the presence and absence of PKC (Shibuya et al., 1998; Shirakawa et al., 2005), 
kinome analysis after cross-linking of DNAM-1 (Konig et al., 2012), transcriptional 
profiling of PKC isozymes in mouse and human NK cells (http://www.immgen.org/), and 
analysis of PKCq-deficient (Prkcq-/-) mice after MCMV infection (Tassi et al., 2008).  To 
address whether Fyn and PKC are directly involved in downstream signaling of DNAM-
1, Cd226-/- hematopoietic progenitor cells (HPCs) were transduced with retroviral 
vectors encoding WT DNAM-1, a S326F mutant in a PKC-binding motif, a Y319F 
mutant in a Fyn-binding site, or a SFYF mutant with both mutations.  Lethally irradiated 
recipient mice were reconstituted with the Cd226-/- BM cells transduced with WT or 
mutant DNAM-1 (hereafter referred to as “DNAM-1 rescued”) mixed with WT BM cells.  
WT DNAM-1-rescued and Y319F (Fyn-binding) mutant DNAM-1-rescued Cd226-/- 
Ly49H+ NK cells expanded similarly to WT Ly49H+ NK cells in Ly49H-deficient recipient 
mice after MCMV infection (Figure 4A).  By contrast, the S326F (PKCh-binding) and 
SFYF double mutant DNAM-1-rescued Cd226-/- Ly49H+ NK cells showed a lower 
magnitude of initial response compared to WT DNAM-1-rescued Ly49H+ NK cells 
(Figure 4A).  On the other hand, Cd226-/- Ly49H+ NK cells expressing any of the three 
mutant forms of DNAM-1 failed to efficiently differentiate into long-lived NK cells (Figure 
4B).   
To confirm the roles of Fyn and PKCh in the differentiation of Ly49H+ NK cells 
during MCMV infection, we produced mixed BM chimeras of WT and Fyn-deficient (Fyn-
/-) cells, or WT and PKCh-deficient (Prkch-/-) cells, so that WT and Fyn-/- or Prkch-/- NK 
cells would develop in the same environment.  After reconstitution, Ly49H+ NK cells 
sufficient or deficient in Fyn or PKCh were purified from mixed BM chimeric mice, 
transferred into Ly49H-deficient mice, and infected with MCMV.  Fyn-deficient Ly49H+ 
NK cells proliferated equivalently to WT Ly49H+ NK cells during the first week post-
infection, but differentiated poorly into a memory subset (Figure 4C and Figure S4A); 
however, Fyn-deficient memory NK cells did expand when adoptively transferred into 
naïve Ly49H-deficient recipient mice and re-challenged with MCMV (Figure 4D).  In 
contrast, PKCh-deficient Ly49H+ NK cells showed a dampened initial response, and 
impaired differentiation into long-lived NK cells with a defective secondary MCMV-
induced expansion of these memory NK cells when transferred into naïve Ly49H-
deficient recipients (Figures 4E and 4F and Figures S4B).  The results with the DNAM-
1-rescued donor Cd226-/- Ly49H+ NK cells are consistent with the phenotypes of Ly49H+ 
NK cells deficient in Fyn and PKCh, and strongly suggest that the DNAM-1-Fyn 
signaling axis is required for the efficient generation of memory NK cells but is 
dispensable for expansion of both effector NK cells and memory NK cells, whereas 
DNAM-1-dependent PKCh signaling is required for both the expansion of effector NK 
cells and memory NK cell generation. 
 
DNAM-1 on Ly49H+ NK cells is dynamically regulated during MCMV infection 
In WT mice, the frequency of Ly49H+DNAM-1- NK cells increased after MCMV infection 
in a virus dose-dependent manner (Figure 5A). The down-modulation of DNAM-1 on 
DNAM-1+ NK cells or expansion of DNAM-1- NK cells was observed only on Ly49H+ NK 
cells after infection with MCMV, but was not down-modulated on Ly49H- NK cells 
(Figure 5A).  Moreover, the loss of DNAM-1 was not observed when mice were infected 
with a MCMV mutant strain lacking m157 (Figure 5B). 
 To determine whether the increase of Ly49H+DNAM-1- NK cells is caused by 
preferential expansion of Ly49H+DNAM-1- NK cells, WT NK cells labeled with the 
CellTrace Violet dye were adoptively transferred into Ly49H-deficient mice. The 
transferred NK cells did not undergo homoeostatic proliferation in the recipient in the 
absence of infection because the Ly49H-deficient mice express normal numbers of 
endogenous NK cells (data not shown). The adoptively transferred DNAM-1- and 
DNAM-1+ Ly49H+ NK cells divided equivalently early during MCMV infection (Figure 
5C).  We observed that the expression of DNAM-1 on Ly49H+ NK cells was transiently 
up-regulated after infection, but thereafter DNAM-1-negative or low Ly49H+ NK cells 
accumulated during the course of infection (Figure 5D), consequently most memory NK 
cells were DNAM-1-negative (Figure 5E).  Interestingly, a higher frequency of DNAM-1+ 
Ly49H+ NK cells stained for Annexin V at days 3 and 6 pi compared with DNAM-1-
Ly49H+ NK cells, suggesting that the predominance of DNAM-1- Ly49H+ NK cells might 
be due to preferential survival of DNAM-1-NK cells (Figure 5F; Figure S5).   
 When naive DNAM-1- and DNAM-1+ NK cells were purified and transferred into 
Ly49H-deficient hosts and infected with MCMV, the sorted DNAM-1+ NK cells 
progressively lost expression of DNAM-1 (Figure 6).  The sorted DNAM-1- NK cell 
population transiently up-regulated DNAM-1, but over the course of infection DNAM-1-
Ly49H+ NK cells accumulated and predominated at day 28 pi (Figure 6).  Similarly, 
when memory DNAM-1- Ly49H+ NK cells were isolated and adoptively transferred into a 
Ly49H-deficient naive host and re-challenged with MCMV, there was transient up-
regulation of DNAM-1 (data not shown).  These results indicate that DNAM-1 on Ly49H+ 
NK cells is dynamically regulated during MCMV infection. 
 
DNAM-1 ligands are up-regulated after MCMV infection in vivo 
We investigated whether the DNAM-1 ligands are modulated in the host during MCMV 
infection.   Although HCMV down-regulates DNAM-1 ligands on human cells infected in 
vitro (Prod'homme et al., 2010; Tomasec et al., 2005), changes in DNAM-1 ligand 
expression in vivo after MCMV infection had not been determined. CD155 and CD112 
were rapidly up-regulated on splenic DCs and macrophages after MCMV infection 
(Figure 7A).  Infection of floxed YFP reporter mice with MCMV encoding Cre 
demonstrated that a small percentage of DCs and macrophages was positive for YFP 
on days 1 and 3 pi (Figure 7B), consistent with a previous study using a MCMV 
encoding GFP (Hsu et al., 2009).  Furthermore, infection with GFP-MCMV revealed that 
infected DC and macrophages highly expressed DNAM-1 ligands as compared with 
non-infected cells (Figure 7C).  These results suggest that DNAM-1 ligands are up-
regulated on DCs and macrophages during MCMV infection, allowing DNAM-1+ Ly49H+ 
NK cells to engage DNAM-1 ligand-expressing cells in lymphoid tissues.  Collectively, 
our findings reveal that DNAM-1 signaling through Fyn and PKCh works in conjunction 
with the m157-specific Ly49H receptor to enhance the immune response against MCMV 
and generate long-lived memory NK cells.   
  
Discussion 
Here, we have demonstrated that DNAM-1 is essential for the optimal function and 
differentiation of Ly49H+ NK cells during MCMV infection.  Although the precise 
molecular mechanisms underlying adaptive immune features of MCMV-specific NK cells 
remain mostly unknown, we have determined that signaling through DNAM-1 is one of 
the critical factors for the initial expansion of effector Ly49H+ NK cells, as well as the 
generation and secondary expansion of memory Ly49H+ NK cells.   
The expansion and generation of memory Ly49H+ NK cells induced by DAP12-
mediated, immunoreceptor tyrosine-based activation motif (ITAM)-dependent signaling 
and the kinetics of the Ly49H+ NK cell response are quite similar to the adaptive 
immune features of virus-specific CD8+ T cells (Sun et al., 2009).  We have identified 
Fyn and PKCh as downstream components of the DNAM-1 transmitted signals 
necessary for the differentiation of Ly49H+ NK cells during MCMV infection.  
Remarkably, these signaling molecules are differentially required at distinct stages of 
NK cell differentiation. DNAM-1-induced Fyn signaling contributed to the efficient 
generation of memory NK cells, but was dispensable for the initial proliferation of NK 
cells as well as the secondary expansion of memory NK cells, whereas the DNAM-1-
PKCh!signaling axis was essential for both expansion of effector NK cells and the 
efficient generation of memory NK cells.  In T cells, Fyn and Lck are required for optimal 
T cell receptor (TCR)-mediated signaling (Salmond et al., 2009; Stein et al., 1992).  Fyn-
deficient T cells demonstrate a reduced calcium influx and proliferative responses, but 
normal Akt kinase phosphorylation, after engagement of their TCRs because of the 
functional redundancy of Lck (Salmond et al., 2009).  In contrast to T cells, the role of 
Src family kinases in NK cells is still not understood well.  In mouse NK cells, Fyn and 
Lck are physically and functionally associated with the DAP12 and Ly49D signaling 
complex (Mason et al., 2006), another activating receptor similar to Ly49H (Smith et al., 
1998).  Although Fyn-deficient mice display alternation in their Ly49 repertoire (Lowin-
Kropf et al., 2002), Fyn-deficient Ly49D+ NK cells efficiently lyse YAC-1 and CHO target 
cells and secrete IFN-g comparably to WT Ly49D+ NK cells (Mason et al., 2006). Fyn is 
capable of phosphorylating DAP12, and Ly49D stimulation reciprocally promotes 
phosphorylation of Fyn (Mason et al., 2006).  Because an activation signal through 
DNAM-1 is mediated by Fyn but not Lck (Shibuya et al., 1999), activation of Fyn through 
DNAM-1 might contribute to enhanced Ly49H-induced phosphorylation of DAP12, 
leading to optimal signaling for the differentiation of memory Ly49H+ NK cells.  Unlike 
Ly49H+ NK cells deficient in PKCh and DNAM-1, Fyn-deficient Ly49H+ NK cells mount a 
normal proliferation responses to MCMV, similar to the intact, albeit reduced, 
proliferation of Fyn-deficient T cells responding to antigenic challenge (Stein et al., 
1992). 
DNAM-1 co-stimulates the proliferation of CD8+ T cells (Nabekura et al., 2010) 
and DNAM-1-induced activation is partly mediated by PKC (Shibuya et al., 1998; 
Shirakawa et al., 2005).  Fu et al. demonstrated a pivotal role of PKCh in the 
proliferation, calcium influx, and NF-kB signaling in T cells, and PKCh and PKCq share 
functional redundancies in T cells (Fu et al., 2011).  By contrast, PKCq in NK cells is 
dispensable for cytotoxicity and control of early MCMV infection (Tassi et al., 2008).  
Although our findings do not exclude the possibility that other PKC isozymes participate 
in NK cell activation, our results clearly demonstrate a critical role of PKCh in the 
adaptive immune features of NK cells responding to MCMV infection.  With regard to 
the virus-specific expansion of effector NK cells, the phenotypes of Ly49H+ NK cells 
deficient in DNAM-1, Fyn, and PKCh during MCMV infection are shared with the 
antigen-specific proliferation of T cells deficient in these molecules (Fu et al., 2011; 
Nabekura et al., 2010; Stein et al., 1992).  However, the role of DNAM-1 in the 
differentiation of memory NK cells and T cells has not been appreciated previously.  
Previous studies have reported that a deficiency of Fyn has no significant impact on 
survival of naïve and memory T cells (Seddon and Zamoyska, 2002), and PKCh-
deficient T cells exhibit identical sensitivity to cell death as WT T cells (Fu et al., 2011).  
Thus, NK cells and T cells may possess unique cell-specific molecular requirements for 
the generation and persistence of memory cells. 
An optimal differentiation of MCMV-specific NK cells is governed not only by the 
distinct downstream signaling components of DNAM-1 but also by the temporal 
regulation of DNAM-1 signaling during the infection.  Because DNAM-1 ligands are 
constitutively expressed by hematopoietic and epithelial cells (Aoki et al., 1997; 
Nabekura et al., 2010; Ravens et al., 2003), up-regulation of either DNAM-1 or its 
ligands might enable Ly49H+ NK cells bearing DNAM-1 to receive activating signal 
through DNAM-1 in addition to Ly49H during MCMV infection. Infection of human cells 
with HCMV in vitro results in the down-regulation of DNAM-1 ligands (Prod'homme et 
al., 2010; Tomasec et al., 2005).  In contrast, DNAM-1 ligands on DCs and 
macrophages are strongly up-regulated by signaling through TLR3 and TLR9 (Kamran 
et al., 2013; Pende et al., 2006), which are essential for innate immune defense against 
MCMV infection (Tabeta et al., 2004).  Our results demonstrate that DNAM-1 ligands 
are rapidly up-regulated on DCs in MCMV-infected mice, while DNAM-1 on Ly49H+ NK 
cells is temporally up-regulated at the same timing.  One possible scenario is that the 
kinetics of expression of DNAM-1 enable Ly49H+ NK cells to receive adequate DNAM-1 
signaling in the context of up-regulated DNAM-1 ligands on infected DCs during MCMV 
infection, consequently allowing Ly49H+ NK cells to control viral burden in the early 
phase, as well as to receive sustained DNAM-1 signaling for optimal expansion and 
differentiation of memory NK cells.  Our findings indicate that cooperative signaling 
through multiple activating receptors regulates the adaptive immune features of NK 
cells. Further studies of the signaling adaptor molecules, cytokines, transcriptional 
factors, and activating and inhibitory receptors to more deeply understand the molecular 
mechanisms underlying the differentiation of NK cells will pave the way for the 
development of new NK cell-based vaccines and therapies against infectious diseases 
and malignancies. 
  
Experimental procedures 
Mice and MCMV 
C57BL/6 and congenic CD45.1+ mice were purchased from the National Cancer 
Institute.  DNAM-1-deficient (Cd226-/-) mice (Iguchi-Manaka et al., 2008) on a C57BL/6 
background were bred and maintained at University of Tsukuba in accordance with the 
guidelines of the Institutional Review Committee of University of Tsukuba.  Congenic 
CD45.1+, Fyn (Fyn-/-)-deficient (Stein et al., 1992), Ly49H-deficient (Fodil-Cornu et al., 
2008), DAP12 (Tyrobp-/-)-deficient (Bakker et al., 2000), flox-stop-flox ROSA26-YFP, 
Cre-dependent YFP reporter mice (Srinivas et al., 2001), and PKCh (Prkch-/-)-deficient 
mice (Fu et al., 2011) on a C57BL/6 background were maintained at the University of 
California, San Francisco and The Scripps Research Institute in accordance with the 
guidelines of the Institutional Animal Care and Use Committee.  Mixed BM chimeric 
mice were generated as described previously (Sun et al., 2009).  Smith strain WT 
MCMV, Dm157 MCMV, and GFP-MCMV were prepared in C57BL/6 3T3 cells, and Cre-
MCMV was prepared in BALB/c mice as described previously (Bubić et al., 2004; Cicin-
Sain et al., 2005; Henry et al., 2000).  Mice were infected by intraperitoneal injection of 
1 x 105, 5 x 105, and 1 x 106 plaque-forming units (pfu) WT MCMV, Dm157 MCMV, GFP-
MCMV, respectively, or 2 x 104 pfu Cre-MCMV.  In some experiments, mice were 
inoculated intraperitoneally with 100 mg of TX42.1, a non-depleting, neutralizing rat mAb 
against mouse DNAM-1 (Nabekura et al., 2010), or an isotype-matched rat IgG2a on 
the day before infection and day 3 pi, or days 7, 14, and 21 pi. 
 
NK cell enrichment and adoptive transfer 
NK cells were enriched by incubating splenocytes with purified rat mAbs against mouse 
CD4, CD5, CD8, CD19, Gr-1, and Ter119, followed by anti-rat IgG antibodies 
conjugated to magnetic beads (Qiagen). NK cells were enriched from BM chimeric mice 
5 weeks or later post-BM transplantation. DNAM-1+ and DNAM-1- NK cells, or WT and 
Cd226-/- NK cells were purified by using a FACSAria III (BD Biosciences).  One to four 
hundred thousand Ly49H+ NK cells were injected intravenously into syngeneic Ly49H-
deficient or DAP12-deficient recipient mice on the day before MCMV infection. 2.5 x 107 
splenocytes were labeled with 10 mM CellTrace Violet according to the manufacturer’s 
instructions (Invitrogen) before intravenous injection of adoptively transferred NK cells. 
 
Transplantation of transduced HPCs 
Retroviral vectors MCSV2.2-IRES-GFP encoding WT DNAM-1, DNAM-1 mutated at a 
PKC-binding site (S326F mutant), DNAM-1 mutated at a Fyn-binding site (Y319F 
mutant), and SFYF mutant DNAM-1 with both mutations (Shirakawa et al., 2006) were 
prepared by calcium phosphate co-transfection of these retroviral constructs and 
expression vectors encoding MuLV gag-pol and vesicular stomatitis virus G protein into 
293T cells according to the manufacturer’s instructions (Promega).  Retroviruses were 
concentrated by overnight centrifugation and viral titers were determined by infection of 
293T cells.  BM cells were isolated from Cd226-/- mice, and HPCs were enriched by 
Ficoll-Paque gradient centrifugation of BM cells, and then incubated with purified rat 
mAbs against mouse CD4, CD5, CD8, CD11b, CD19, Gr-1, Ter119, and NKp46, 
followed by anti-rat IgG antibodies conjugated to magnetic beads (Qiagen).  HPCs were 
cultured in StemPro34 (Invitrogen) in the presence of 10 ng/ml mouse IL-3, 30 ng/ml 
human IL-6, and 50 ng/ml mouse stem cell factor (PeproTech) on Retronectin-coated 
culture plates (Clontech).  HPCs were transduced with retroviruses on days 1 and 2 
(Nabekura et al., 2006).  One to ten thousand transduced Cd226-/- HPCs were mixed 
with CD45.1+CD45.2+ WT HPCs, and transplanted into lethally irradiated recipient mice 
(550 rad x 2, 4 h interval) on day 2.5. 
Flow cytometry 
Fc receptors were blocked with 2.4G2 mAb before surface or intracellular staining with 
the indicated mAbs or isotype-matched control antibodies (BD Biosciences, 
eBioscience, or BioLegend).  For measuring apoptosis, freshly isolated splenocytes 
were stained with antibodies against cell surface molecules and APC-conjugated 
Annexin V (BD Biosciences) according to the manufacturer’s protocol.  Samples were 
acquired on an LSRII or a FACSCalibur (BD Biosciences) and analyzed with FlowJo 
software (Tree Star). 
 
Measurement of MCMV load 
C57BL/6 mice were inoculated intraperitoneally with 100 mg of TX42.1, a neutralizing 
mAb against DNAM-1, or an isotype-matched rat IgG2a on the day before infection, 
followed by infection with 5 x 105 pfu MCMV.  On day 3 pi, one lobe of each liver and 
spleen were homogenized in DMEM.  Cell homogenates were plated on C57BL/6 3T3 
cells in ten-fold serial dilutions and incubated for 2 h at 37 o C.  DMEM with 10% FCS 
and 0.75% carboxymethyl cellulose was added and samples were incubated for 9 days.  
Plaques were counted under a light microscopy.  Viral titers in the spleen were 
calculated for the whole organ and titers in the liver were adjusted for weight of the 
tissue.  The copy number of MCMV IE1 gene in DNA prepared from peripheral blood on 
days 3 and 7 pi was determined by quantitative PCR analysis using a SYBR green 
master mix reagent (Invitrogen) and the following primer pair; MCMV IE1 Forward: 5'-
AGCCACCAACATTGACCACGCAC-3', MCMV IE1 Reverse: 5'-
GCCCCAACCAGGACACACAACTC-3'.  A plasmid encoding MCMV IE1 was used for 
the standard curve. 
 
Ex vivo stimulation of NK cells 
One million splenocytes were co-cultured with 1 x 105 RMA transfectants expressing 
m157, CD155, or m157 and CD155 for 6 h at 37o C in the presence of PE-conjugated 
anti-CD107a mAb, GolgiStop, and GolgiPlug (BD Biosciences), followed by staining for 
surface molecules and intracellular IFN-g. 
 
Statistical methods 
Student’s t-test was used to compare results.  The Mann–Whitney U test was used to 
compare groups in a PCR-based viral titer assay.  p <0.05 was considered statistically 
significant. 
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Sjölin, H., Tomasello, E., Mousavi-Jazi, M., Bartolazzi, A., Kärre, K., Vivier, E., and Cerboni, C. 
(2002). Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated 
resistance to murine cytomegalovirus infection. J Exp Med 195, 825-834. 
 
Smith, H.R., Heusel, J.W., Mehta, I.K., Kim, S., Dorner, B.G., Naidenko, O.V., Iizuka, K., 
Furukawa, H., Beckman, D.L., Pingel, J.T., et al. (2002). Recognition of a virus-encoded ligand 
by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 99, 8826-8831. 
 
Smith, K.M., Wu, J., Bakker, A.B., Phillips, J.H., and Lanier, L.L. (1998). Ly-49D and Ly-49H 
associate with mouse DAP12 and form activating receptors. J Immunol 161, 7-10. 
 
Srinivas, S., Watanabe, T., Lin, C.S., William, C.M., Tanabe, Y., Jessell, T.M., and Costantini, F. 
(2001). Cre reporter strains produced by targeted insertion of EYFP and ECFP into the 
ROSA26 locus. BMC Dev Biol 1, 4. 
 
Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., Levine, Z., Beiman, M., 
Dassa, L., Achdout, H., et al. (2009). The interaction of TIGIT with PVR and PVRL2 inhibits 
human NK cell cytotoxicity. Proc Natl Acad Sci U S A 106, 17858-17863. 
 
Stein, P.L., Lee, H.M., Rich, S., and Soriano, P. (1992). pp59fyn mutant mice display 
differential signaling in thymocytes and peripheral T cells. Cell 70, 741-750. 
 
Sun, J.C., Beilke, J.N., and Lanier, L.L. (2009). Adaptive immune features of natural killer 
cells. Nature 457, 557-561. 
 
Sun, J.C., Beilke, J.N., and Lanier, L.L. (2010). Immune memory redefined: characterizing the 
longevity of natural killer cells. Immunol Rev 236, 83-94. 
 
Sun, J.C., and Lanier, L.L. (2011). NK cell development, homeostasis and function: parallels 
with CD8⁺ T cells. Nat Rev Immunol 11, 645-657. 
 
Sun, J.C., Lopez-Verges, S., Kim, C.C., DeRisi, J.L., and Lanier, L.L. (2011). NK cells and 
immune "memory". J Immunol 186, 1891-1897. 
 
Sun, J.C., Madera, S., Bezman, N.A., Beilke, J.N., Kaplan, M.H., and Lanier, L.L. (2012). 
Proinflammatory cytokine signaling required for the generation of natural killer cell 
memory. J Exp Med 209, 947-954. 
 
Tabeta, K., Georgel, P., Janssen, E., Du, X., Hoebe, K., Crozat, K., Mudd, S., Shamel, L., Sovath, S., 
Goode, J., et al. (2004). Toll-like receptors 9 and 3 as essential components of innate 
immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A 101, 
3516-3521. 
 
Tahara-Hanaoka, S., Shibuya, K., Kai, H., Miyamoto, A., Morikawa, Y., Ohkochi, N., Honda, S., 
and Shibuya, A. (2006). Tumor rejection by the poliovirus receptor family ligands of the 
DNAM-1 (CD226) receptor. Blood 107, 1491-1496. 
 
Tahara-Hanaoka, S., Shibuya, K., Onoda, Y., Zhang, H., Yamazaki, S., Miyamoto, A., Honda, S., 
Lanier, L.L., and Shibuya, A. (2004). Functional characterization of DNAM-1 (CD226) 
interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int Immunol 16, 
533-538. 
 
Tassi, I., Cella, M., Presti, R., Colucci, A., Gilfillan, S., Littman, D.R., and Colonna, M. (2008). NK 
cell-activating receptors require PKC-theta for sustained signaling, transcriptional 
activation, and IFN-gamma secretion. Blood 112, 4109-4116. 
 
Tomasec, P., Wang, E.C., Davison, A.J., Vojtesek, B., Armstrong, M., Griffin, C., McSharry, B.P., 
Morris, R.J., Llewellyn-Lacey, S., Rickards, C., et al. (2005). Downregulation of natural killer 
cell-activating ligand CD155 by human cytomegalovirus UL141. Nat Immunol 6, 181-188. 
 
  
Figure legends 
Figure 1. Phenotype of DNAM-1+ and DNAM-1- NK cells. 
(A) Expression of DNAM-1 on NK cells in the spleen, blood, BM, and liver, gating on 
TCRb-NK1.1+ lymphocytes.  Thin and bold lines represent staining with control Ig and 
anti-DNAM-1 mAb.  (B) Developmental stages of DNAM-1+ and DNAM-1- NK cells as 
determined by co-staining with CD27 and CD11b, gating on TCRb-NK1.1+ lymphocytes.  
(C) Ly49H expression on DNAM-1+ (thick lines) and DNAM-1- (thin lines) NK cells, 
gated on TCRb-NK1.1+ lymphocytes.  Percentages of Ly49H+ NK cells in DNAM-1+ 
(bold numbers) and DNAM-1- NK (thin numbers) cells are shown.  (D) Expression of 
Ly49C and/or Ly49I on DNAM-1+ (thick lines) and DNAM-1- (thin lines) NK cells.  Data 
are representative of 2-4 experiments.  (E) IFN-g production and degranulation of 
Ly49H+DNAM-1+ and Ly49H+DNAM-1- NK cells after co-culture with RMA cells 
expressing m157, CD155, or m157 and CD155.  Data are representative of 2 
independent experiments (n = 3-6 per experiment).  (F) Twenty-five million WT 
splenocytes were transferred into DAP12-deficient mice and infected with 1 x 105 pfu 
MCMV.  IFN-g production by Ly49H+ NK cells was analyzed by intracellular staining on 
day 1.5 pi.  Percentages of IFN-g+Ly49H+ NK cells and mean fluorescent intensity (MFI) 
of IFN-g of Ly49H+ NK cells within the DNAM-1+ and DNAM-1- Ly49H+ NK cell subsets 
are shown.  Data are representative of 3 experiments (n = 3-4 mice per experiment). 
Error bars show s.e.m. *p <0.05. 
 
Figure 2. DNAM-1 antibody blockade suppresses the NK cell response to MCMV. 
(A) WT mice were inoculated with control Ig or a neutralizing mAb against DNAM-1 on 
the day before infection with 5 x 105 pfu MCMV.  Viral burden in the liver and spleen 
was measured on day 3 pi.  (B) One hundred thousand WT Ly49H+ NK cells were 
transferred into DAP12-deficient mice and infected with 1 x 105 pfu MCMV.  Mice were 
inoculated with 100 mg control Ig or anti-DNAM-1 mAb on the day before infection and 
day 3 pi.  The absolute number of Ly49H+ NK cells per ml blood.  (C) DAP12-deficient 
mice receiving 1 x 105 WT Ly49H+ NK cells were infected with MCMV, and treated with 
100 mg control Ig or anti-DNAM-1 mAb on days 7, 14, and 21 pi.  The absolute number 
of Ly49H+ NK cells per ml blood and percentages of Ly49H+ memory NK cells in the 
spleen on day 28 pi.  Data were pooled from 2 experiments (n = 6 mice per mAb group).  
Error bars show s.e.m. *p <0.05, **p <0.01.  See also Figure S1.  
 
Figure 3. DNAM-1 is required for expansion of effector NK cells and differentiation 
of memory NK cells during MCMV infection. 
(A) NK cells were purified from WT and Cd226-/- mixed BM chimeric mice.  One hundred 
fifty thousand WT and Cd226-/- Ly49H+ NK cells were transferred into Ly49H-deficient 
mice and infected with 1 x 105 pfu MCMV.  (B) Activation markers CD69 and KLRG1 on 
Ly49H+ NK cells at day 1.5 and 7 pi, respectively, and IFN-g production on day 1.5 pi.  
Thin and bold lines represent Cd226-/- Ly49H+ and WT Ly49H+ NK cells.  (C) Phenotype 
of WT and Cd226-/- naïve, effector (day 7 pi), and memory (day 25 pi) NK cells.  
Expression of KLRG1, CD11b, CD27, and Ly6C on Ly49H+ NK cells is shown.  (D) The 
kinetics of the absolute number of Ly49H+ NK cells in blood were represented as the 
ratio relative to the number of Ly49H+ NK cells in the blood on day 0 (before infection).  
Data are representative of 3 experiments (n = 6-7 mice).  (E) Memory NK cells were 
isolated from recipient mice 30 days after primary infection, transferred into naïve 
Ly49H-deficient mice, and infected with MCMV.  Secondary expansion of 
Ly49H+memory NK cells in the spleen on day 7 after infection with MCMV was 
represented as the fold expansion relative to the number of memory NK cells detected 
in the spleen of mice adoptively transferred with an aliquot of Ly49H+ memory NK cells 
but not infected with MCMV.  Data are pooled from 2 experiments (n = 6 mice).  (F and 
G) WT and Cd226-/- memory NK cells were purified from recipient mice 25-28 days after 
primary infection, and WT and Cd226-/- naïve NK cells were purified from BM chimeric 
mice.  Ten thousand WT and Cd226-/- naïve and memory Ly49H+ NK cells were 
transferred separately into Ly49H-deficient or DAP12-deficient mice and infected with 
MCMV.  The copy number of MCMV IE1 gene in blood on day 3 pi (F) and day 7 pi (G) 
was analyzed by quantitative PCR.  Data were pooled from 2 experiments (n = 6-8 mice 
per group).  *p <0.05, **p <0.01, and ***p <0.005.  Error bars show s.e.m.  See also 
Figure S2 and S3.  
 
Figure 4. DNAM-1 signaling is required for optimal differentiation of Ly49H+ NK 
cells during MCMV infection. 
(A and B) NK cells were purified from BM chimeric mice reconstituted with WT, Cd226-/-, 
and DNAM-1-rescued Cd226-/- HPCs.  Ly49H+ NK cells were isolated from chimeric 
mice and transferred into Ly49H-deficient mice, and then infected with 1 x 105 pfu 
MCMV.  The number of Cd226-/- and DNAM-1-rescued Ly49H+ effector NK cells on day 
7 pi (A) and memory NK cells on day 25 pi (B) in the spleen was represented as the fold 
expansion relative to the number of WT Ly49H+ NK cells on days 7 and 25 pi in the 
spleen.  Data are pooled from 2 experiments (n = 4 mice per rescued construct).  *p 
<0.05.  (C-F) NK cells were purified from BM chimeric mice of WT and Fyn-/- mice, or 
WT and Prkch-/- mice.  WT and Fyn-/- Ly49H+ NK cells (4 x 105 cells), or WT and Prkch-/- 
Ly49H+ NK cells (1 x 105 cells) were transferred into Ly49H-deficient mice and infected 
with MCMV.  (C and E) The kinetics of the absolute number of Ly49H+ NK cells in blood 
were represented as the ratio relative to the number of Ly49H+ NK cells in blood on day 
0 (before infection).  (D and F) Memory NK cells were transferred into naïve Ly49H-
deficient mice and infected with MCMV.  Secondary expansion of Ly49H+ memory NK 
cells in the spleen on day 7 after infection with MCMV was represented as the fold 
expansion relative to the number of memory NK cells detected in the spleen of mice 
adoptively transferred with an aliquot of Ly49H+ memory NK cells but not infected with 
MCMV.  Data are representative of 2-3 experiments (n = 3-5). Error bars show s.e.m. *p 
<0.05.  See also Figure S4. 
 
 
Figure 5. DNAM-1 on Ly49H+ NK cells is modulated during MCMV infection. 
(A) DNAM-1 on Ly49H+ NK cells in the spleen of mice infected with MCMV on day 7 pi.  
Data are representative of 2 experiments (n =2-3 in each group). (B) Percentages of 
DNAM-1-negative NK cells within the Ly49H+ and Ly49H- NK cell subsets in the blood 
of mice infected with 5 x 105 pfu WT or Dm157 MCMV.  *p <0.05 vs. the other 3 groups.  
(C) Twenty-five million CellTrace Violet-labeled splenocytes were transferred into 
DAP12-deficient mice and infected with 1 x 105 pfu MCMV.  Expression of DNAM-1 on 
Ly49H+ NK cells in the spleen was analyzed on days 3 and 6 pi.  Data are 
representative of 3 experiments (n = 3-4 mice per time point) (B and C).  (D and E) One 
or two hundred thousand CD45.1+Ly49H+ NK cells were transferred into Ly49H-
deficient mice and infected with MCMV.  (D) MFI of DNAM-1 on Ly49H+ NK cells in the 
spleen.  Data were pooled from 6 experiments (n = 3-5 mice per time point).  *p <0.05, 
**p <0.01 vs. day 0.  (E) DNAM-1 on CD45.1+Ly49H+ memory NK cells in the spleen on 
day 35 pi.  Data are representative of more than 5 experiments.  (F) Twenty-five million 
WT splenocytes were transferred into DAP12-deficient mice and infected with MCMV.  
Cell death of Ly49H+ NK cells was analyzed by Annexin V staining on days 3 and 6 pi.  
Data are representative of 3 experiments (n = 3-4 mice per experiment).  *p <0.05, **p 
<0.01 vs. DNAM-1-.  Error bars show s.e.m.  See also Figure S5. 
 
 
Figure 6. DNAM-1- and DNAM-1+ NK cells expand and differentiate into memory 
NK cells during MCMV infection. 
One hundred thousand purified Ly49H+DNAM-1+ or Ly49H+DNAM-1- NK cells were 
transferred separately into DAP12-deficient mice and infected with 1 x 105 MCMV.  
Percentages of Ly49H+DNAM-1+ and Ly49H+DNAM-1- NK cells in blood are shown.  
Data are representative of 3 experiments (n = 4-5 mice).  Error bars show s.e.m. 
 
Figure 7. DNAM-1 ligands are upregulated after MCMV infection in vivo. 
(A) WT mice were infected with 1 x 106 pfu MCMV.  Expression of CD155 and CD112 
on hematopoietic cells in the spleen of infected mice on days 1 and 3 pi was analyzed 
by flow cytometry.  NK cells (TCRb-NK1.1+), NKT cells (TCRb+NK1.1+), CD4+ T cells 
(TCRb+CD4+), CD8+ T cells (TCRb+CD8a+), B cells (CD11b-B220+), DCs (CD11chighI-
AE+), granulocytes (Gr; CD11b+Gr-1high), macrophages (Mf; CD11b+Gr-1low) were 
assessed. (B) Cre-dependent YFP reporter mice were infected with 2 x 104 pfu Cre-
MCMV.  YFP+ hematopoietic cells in the spleen of infected mice on days 1 and 3 pi 
were analyzed.  Data are representative of 2 experiments (n = 3 mice per time point) (A 
and B).  *p <0.05 vs. uninfected.  (C) WT mice were infected with 1 x 106 pfu GFP-
MCMV.  Expression of CD155 and CD112 on GFP- and GFP+ DCs and macrophages in 
the spleen was analyzed.  Data are pooled from 3 experiments (n = 5-6 mice per time 
point).  *p <0.05, **p <0.01 vs. GFP-.  Error bars show s.e.m 
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Figure S1. Enrichment of NK cells.   
NK cells were enriched by incubating splenocytes with purified rat mAbs against 
mouse CD4, CD5, CD8, CD19, Gr-1, and Ter119, followed by anti-rat IgG 
antibodies conjugated to magnetic beads (Qiagen).  Cells were stained with 
anti-mouse TCRb and NK1.1.  Data are representative of more than 20 
experiments. 
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Figure S2. DNAM-1 is required for the expansion of effector NK cells and 
differentiation of memory Ly49H+ NK cells during MCMV infection. 
NK cells were purified from CD45.1+CD45.2+ WT and CD45.2+ Cd226-/- mixed BM 
chimeric mice.  One hundred-fifty thousand wildtype (WT) and Cd226-/- Ly49H+ NK 
cells were transferred into Ly49H-deficient mice and infected with 1 x 105 pfu MCMV.  
Donor NK cells in the blood were analyzed on day 0 (before infection) and on days 
7 and 28 pi, gating on Ly49H+ NK cells.  Data are representative of 3 experiments 
(n = 6-7 mice). 
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Figure S3. DNAM-1 is required for the optimal differentiation of memory 
Ly49H+ NK cells during MCMV infection. 
WT and Cd226-/- memory NK cells were purified from recipient mice 25-28 days 
after primary infection, and WT and Cd226-/- naïve NK cells were purified from BM 
chimeric mice.  Ten thousand WT and Cd226-/- naïve and memory Ly49H+ NK 
cells were transferred separately into Ly49H-deficient or DAP12-deficient mice and 
infected with MCMV.  The copy number of MCMV IE1 gene in blood on day 3 pi (A) 
and day 7 pi (B) was analyzed by quantitative PCR.  Scatter plots depicting the 
copy number in individual recipient mice in Figures 3F and 3G are shown in panels 
S3A and S3B, respectively.  Data were pooled from 2 experiments (n = 6-8 mice 
per group). 
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Figure S4. Fyn and PKCh are required for the optimal differentiation of 
memory Ly49H+ NK cells during MCMV infection. 
NK cells were purified from CD45.1+CD45.2+ WT and CD45.2+ Fyn-/- mixed BM 
chimeric mice, or CD45.1+ WT and CD45.2+ Prkch-/- mixed BM chimeric mice.  
WT and Fyn-/- Ly49H+ NK cells (4 x 105 cells) (A), or WT and Prkch-/- Ly49H+ NK 
cells (1 x 105 cells) (B) were transferred into Ly49H-deficient mice and infected with 
1 x 105 pfu MCMV.  Donor NK cells in the blood were analyzed on day 0 (before 
6 
 
infection) and on days 7 and 28 pi, gating on Ly49H+ NK cells.  Data are 
representative of 2-3 experiments (n = 3-5). 
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Figure S5. DNAM-1+Ly49H+ NK cells are sensitive to cell death during MCMV 
infection. 
Twenty-five million WT splenocytes were transferred into DAP12-deficient mice and 
infected with 1 x 105 PFU MCMV.  Cell death of Ly49H+ NK cells was analyzed by 
annexin V staining on days 3 and 6 pi.  Thin and bold lines represent 
DNAM-1-Ly49H+ and DNAM-1+Ly49H+ NK cells, respectively.  Data are 
representative of 3 experiments (n = 3-4 mice per experiment). 
